Maternal hyperglycemia leads to fetal cardiac hyperplasia and dysfunction in a rat model

Lara Lehtoranta, Olli Vuolteenaho, V. Jukka Laine, Anna Koskinen, Hanna Soukka, Ville Kytö, Jorma Määttä, Mervi Haapsamo, Eeva Ekholm, Juha Räsänen

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Accelerated fetal myocardial growth with altered cardiac function is a well-documented complication of human diabetic pregnancy, but its pathophysiology is still largely unknown. Our aim was to explore the mechanisms of fetal cardiac remodeling and cardiovascular hemodynamics in a rat model of maternal pregestational streptozotocin-induced hyperglycemia. The hyperglycemic group comprised 107 fetuses (10 dams) and the control group 219 fetuses (20 dams). Fetal cardiac function was assessed serially by Doppler ultrasonography. Fetal cardiac to thoracic area ratio, newborn heart weight, myocardial cell proliferative and apoptotic activities, and cardiac gene expression patterns were determined. Maternal hyperglycemia was associated with increased cardiac size, proliferative, apoptotic and mitotic activities, upregulation of genes encoding A- and B-type natriuretic peptides, myosin heavy chain types 2 and 3, uncoupling proteins 2 and 3, and the angiogenetic tumor necrosis factor receptor superfamily member 12A. The genes encoding Kv channel-interacting protein 2, a regulator of electrical cardiac phenotype, and the insulin-regulated glucose transporter 4 were downregulated. The heart rate was lower in fetuses of hyperglycemic dams. At 13-14 gestational days, 98% of fetuses of hyperglycemic dams had holosystolic atrioventricular valve regurgitation and decreased outflow mean velocity, indicating diminished cardiac output. Maternal hyperglycemia may lead to accelerated fetal myocardial growth by cardiomyocyte hyperplasia. In fetuses of hyperglycemic dams, expression of key genes that control and regulate cardiomyocyte electrophysiological properties, contractility, and metabolism are altered and may lead to major functional and clinical implications on the fetal heart.

Original languageEnglish (US)
Pages (from-to)E611-E619
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume305
Issue number5
DOIs
StatePublished - Sep 17 2013

Keywords

  • Dysfunction
  • Fetal heart
  • Hyperglycemia
  • Hyperplasia
  • Rats

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Maternal hyperglycemia leads to fetal cardiac hyperplasia and dysfunction in a rat model'. Together they form a unique fingerprint.

  • Cite this

    Lehtoranta, L., Vuolteenaho, O., Jukka Laine, V., Koskinen, A., Soukka, H., Kytö, V., Määttä, J., Haapsamo, M., Ekholm, E., & Räsänen, J. (2013). Maternal hyperglycemia leads to fetal cardiac hyperplasia and dysfunction in a rat model. American Journal of Physiology - Endocrinology and Metabolism, 305(5), E611-E619. https://doi.org/10.1152/ajpendo.00043.2013